Advertisement

Pathology

  • Ethel CesarmanEmail author
  • Amy Chadburn
Chapter

Abstract

This chapter considers issues in molecular and clinical pathology of HIV-related lymphomas, leukemias, and myeloproliferative disorders (MPD). While HIV-associated lymphomas are specifically addressed in the WHO classification, HIV-related leukemias and myeloproliferative disorders are not. The 2008 WHO classification of malignant lymphoma distinguishes lymphoma also occurring in immunocompetent patients from those occurring more specifically in HIV-positive patients, with diffuse large B-cell lymphoma (DLBCL) being most common, followed by Burkitt/Burkitt-like lymphoma and Hodgkin lymphoma (HL).

Keywords

Acute Myeloid Leukemia Chronic Myelogenous Leukemia Polycythemia Vera Standardize Incidence Ratio Anaplastic Large Cell Lymphoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    A review of human carcinogens, Part B: Biological agents. IARC Monographs on the evaluation of carcinogenic risks to humans. Lyon: World Health Organization International Agency for Research on Cancer; 2012.Google Scholar
  2. 2.
    Aboulafia DM, Meneses M, Ginsberg S, Siegel MS, Howard WW, Dezube BJ. Acute myeloid leukemia in patients infected with HIV-1. AIDS. 2002;16:865–76.PubMedCrossRefGoogle Scholar
  3. 3.
    Arvey A, Ojesina AI, Pedamallu CS, Ballon G, Jung J, Duke F, Leoncini L, de Falco G, Bressman E, Tam W, Chadburn A, Meyerson M, Cesarman E. The tumor virus landscape of AIDS-related lymphomas. Blood. 2015;125:e14–22.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Arzoo KK, Bu X, Espina BM, Seneviratne L, Nathwani B, Levine AM. T-cell lymphoma in HIV-infected patients. J Acquir Immune Defic Syndr. 2004;36:1020–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Ashihara E, Shimazaki C, Hirai H, Inaba T, Hasegawa G, Mori S, Nakagawa M. Human herpes virus 8-negative primary effusion lymphoma in a patient with a ventriculoperitoneal shunt tube. Int J Hematol. 2001;74:327–32.PubMedCrossRefGoogle Scholar
  6. 6.
    Asou H, Said JW, Yang R, Munker R, Park DJ, Kamada N, Koeffler HP. Mechanisms of growth control of Kaposi’s sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood. 1998;91:2475–81.PubMedGoogle Scholar
  7. 7.
    Battan R, Ottaviano P, Porcelli M, Distenfeld A. Polycythaemia in patient with AIDS. Lancet. 1990;335:1342–3.PubMedCrossRefGoogle Scholar
  8. 8.
    Bhatia K, Huppi K, Spangler G, Siwarski D, Iyer R, Magrath I. Point mutations in the c-Myc transactivation domain are common in Burkitt’s lymphoma and mouse plasmacytomas. Nat Genet. 1993;5:56–61.PubMedCrossRefGoogle Scholar
  9. 9.
    Bolarinwa RA, Ndakotsu MA, Oyekunle AA, Salawu L, Akinola NO, Durosinmi MA. AIDS-related lymphomas in Nigeria. Braz J Infect Dis. 2009;13:359–61.PubMedCrossRefGoogle Scholar
  10. 10.
    Breccia M, Gentile G, Martino P, Petti MC, Russo E, Mancini M, Alimena G. Acute myeloid leukemia secondary to a myelodysplastic syndrome with t(3;3) (q21;q26) in an HIV patient treated with chemotherapy and highly active antiretroviral therapy. Acta Haematol. 2004;111:160–2.PubMedCrossRefGoogle Scholar
  11. 11.
    Breen EC, Hussain SK, Magpantay L, Jacobson LP, Detels R, Rabkin CS, Kaslow RA, Variakojis D, Bream JH, Rinaldo CR, Ambinder RF, Martinez-Maza O. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma. Cancer Epidemiol Biomarkers Prev. 2011;20:1303–14.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Brunning RD, Orazi A, Germing U, Le Beau MM, Porwit A, Baumann I, Vardiman J, Hellstrom-Lindberg E. Myelodysplastic syndromes/neoplasms. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.Google Scholar
  13. 13.
    Burns BF, Wood GS, Dorfman RF. The varied histopathology of lymphadenopathy in the homosexual male. Am J Surg Pathol. 1985;9:287–97.PubMedCrossRefGoogle Scholar
  14. 14.
    Buxton J, Leen C, Goodlad JR. Polymorphic lymphoid proliferations occurring in HIV-positive patients: report of a case responding to HAART. Virchows Arch. 2012;461:93–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Carbone A. Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol. 2003;4:22–9.PubMedCrossRefGoogle Scholar
  16. 16.
    Carbone A, Gloghini A, Serraino D, Spina M. HIV-associated Hodgkin lymphoma. Curr Opin HIV AIDS. 2009;4:3–10.PubMedCrossRefGoogle Scholar
  17. 17.
    Carbone A, Tirelli U, Gloghini A, Volpe R, Boiocchi M. Human immunodeficiency virus-associated systemic lymphomas may be subdivided into two main groups according to Epstein-Barr viral latent gene expression. J Clin Oncol. 1993;11:1674–81.PubMedGoogle Scholar
  18. 18.
    Castella A, Croxson TS, Mildvan D, Witt DH, Zalusky R. The bone marrow in AIDS. A histologic, hematologic, and microbiologic study. Am J Clin Pathol. 1985;84:425–32.PubMedGoogle Scholar
  19. 19.
    Castillo JJ, Beltran BE, Bibas M, Bower M, Collins JA, Cwynarski K, Diez-Martin JL, Hernandez-Ilizaliturri F, Horwitz SM, Montoto S, Pantanowitz L, Ribera JM, Vose JM. Prognostic factors in patients with HIV-associated peripheral T-cell lymphoma: a multicenter study. Am J Hematol. 2011;86:256–61.PubMedCrossRefGoogle Scholar
  20. 20.
    Cesarman E. Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients. Cancer Lett. 2011;305:163–74.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi’s Sarcoma-associated Herpesvirus-like DNA sequences in AIDS-related body cavity-based lymphomas. N Eng J Med. 1995;332:1186–91.CrossRefGoogle Scholar
  22. 22.
    Cesarman E, Dalla-Favera R, Bentley D, Groudine M. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science. 1987;238:1272–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E. Immunophenotypic analysis of AIDS-related diffuse large B-cell lymphoma and clinical implications in patients from AIDS Malignancies Consortium clinical trials 010 and 034. J Clin Oncol. 2009;27:5039–48.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Chadburn A, Hyjek E, Mathew S, Cesarman E, Said J, Knowles DM. KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol. 2004;28:1401–16.PubMedCrossRefGoogle Scholar
  25. 25.
    Chadburn A, Noy A, Lee JY, Hyjek E, Banham AH, Sparano JA, Bhatia K, Cesarman E. Reply to K Dunleavy et al. J Clin Oncol. 2010;28:e261–2.CrossRefGoogle Scholar
  26. 26.
    Chao C, Silverberg MJ, Martinez-Maza O, Chi M, Abrams DI, Haque R, Zha HD, Mcguire M, Xu L, Said J. Epstein-Barr virus infection and expression of B-cell oncogenic markers in HIV-related diffuse large B-cell lymphoma. Clin Cancer Res. 2012;18:4702–12.PubMedCrossRefGoogle Scholar
  27. 27.
    Chiao EY, Krown SE. Update on non-acquired immunodeficiency syndrome-defining malignancies. Curr Opin Oncol. 2003;15:389–97.PubMedCrossRefGoogle Scholar
  28. 28.
    Choi WW, Weisenburger DD, Greiner TC, Piris MA, Banham AH, Delabie J, Braziel RM, Geng H, Iqbal J, Lenz G, Vose JM, Hans CP, Fu K, Smith LM, Li M, Liu Z, Gascoyne RD, Rosenwald A, Ott G, Rimsza LM, Campo E, Jaffe ES, Jaye DL, Staudt LM, Chan WC. A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res. 2009;15:5494–502.PubMedCrossRefGoogle Scholar
  29. 29.
    Ciobanu N, Andreeff M, Safai B, Koziner B, Mertelsmann R. Lymphoblastic neoplasia in a homosexual patient with Kaposi’s sarcoma. Ann Intern Med. 1983;98:151–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, Bordoni A, de Weck D, Franceschi S. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97:425–32.PubMedCrossRefGoogle Scholar
  31. 31.
    Colomo L, Loong F, Rives S, Pittaluga S, Martinez A, Lopez-Guillermo A, Ojanguren J, Romagosa V, Jaffe ES, Campo E. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol. 2004;28:736–47.PubMedCrossRefGoogle Scholar
  32. 32.
    Colovic N, Jurisic V, Terzic T, Jevtovic D, Colovic M. Alveolar granulocytic sarcoma of the mandible in a patient with HIV. Onkologie. 2011;34:55–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Corti M, Villafane MF, Bistmans A, Campitelli A, Narbaitz M, Bare P. Oral cavity and extra-oral plasmablastic lymphomas in AIDS patients: report of five cases and review of the literature. Int J STD AIDS. 2011;22:759–63.PubMedCrossRefGoogle Scholar
  34. 34.
    Darne C, Solal-Celigny P, Herrera A, Ramond MJ, Brun-Vezinet F, Brousse N, Boivin P. Acute myelofibrosis and infection with the lymphadenopathy-associated virus/human T-lymphotropic virus type III. Ann Intern Med. 1986;104:130–1.PubMedCrossRefGoogle Scholar
  35. 35.
    Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Kvaloy S, Holte H, Fisher RI, Miller TP, Montserrat E, Wilson WH, Bahl M, Zhao H, Yang L, Powell J, Simon R, Chan WC, Staudt LM. Molecular diagnosis of Burkitt’s lymphoma. N Engl J Med. 2006;354:2431–42.PubMedCrossRefGoogle Scholar
  36. 36.
    Deeken JF, Pantanowitz L, Dezube BJ. Targeted therapies to treat non-AIDS-defining cancers in patients with HIV on HAART therapy: treatment considerations and research outlook. Curr Opin Oncol. 2009;21:445–54.PubMedCentralPubMedCrossRefGoogle Scholar
  37. 37.
    Delecluse HJ, Anagnostopoulos I, Dallenbach F, Hummel M, Marafioti T, Schneider U, Huhn D, Schmidt-Westhausen A, Reichart PA, Gross U, Stein H. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997;89:1413–20.PubMedGoogle Scholar
  38. 38.
    Dezube BJ, Aboulafia DM, Pantanowitz L. Plasma cell disorders in HIV-infected patients: from benign gammopathy to multiple myeloma. AIDS Read. 2004;14:372–4, 377–9.PubMedGoogle Scholar
  39. 39.
    Du MQ, Diss TC, Liu H, Ye H, Hamoudi RA, Cabecadas J, Dong HY, Harris NL, Chan JK, Rees JW, Dogan A, Isaacson PG. KSHV- and EBV-associated germinotropic lymphoproliferative disorder. Blood. 2002;100:3415–8.PubMedCrossRefGoogle Scholar
  40. 40.
    Dunleavy K, Wilson WH. Role of molecular subtype in predicting outcome of AIDS-related diffuse large B-cell lymphoma. J Clin Oncol. 2010;28, e260.PubMedCrossRefGoogle Scholar
  41. 41.
    Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, Weiss RA, Isaacson PG, Boshoff C. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95:1406–12.PubMedGoogle Scholar
  42. 42.
    Edwards TB, Nelson RP, Ballester OF, Saba HI, Lockey RF. Polycythemia as a complication of human immunodeficiency virus infection. South Med J. 1993;86:686–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Engels EA, Biggar RJ, Hall HI, Cross H, Crutchfield A, Finch JL, Grigg R, Hylton T, Pawlish KS, Mcneel TS, Goedert JJ. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008;123:187–94.PubMedCrossRefGoogle Scholar
  44. 44.
    Evans MW, Sung AD, Gojo I, Tidwell M, Greer J, Levis M, Karp J, Baer MR. Risk assessment in human immunodeficiency virus-associated acute myeloid leukemia. Leuk Lymphoma. 2012;53:660–4.PubMedCrossRefGoogle Scholar
  45. 45.
    Fiorino AS, Atac B. Paraproteinemia, plasmacytoma, myeloma and HIV infection. Leukemia. 1997;11:2150–6.PubMedCrossRefGoogle Scholar
  46. 46.
    Flanagan P, Chowdhury V, Costello C. HIV-associated B cell ALL. Br J Haematol. 1988;69:287.PubMedCrossRefGoogle Scholar
  47. 47.
    Frisch M, Biggar RJ, Engels EA, Goedert JJ, Group, A. I.-C. M. R. S. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736–45.PubMedCrossRefGoogle Scholar
  48. 48.
    Gaidano G, Carbone A, Dalla-Favera R. Genetic basis of acquired immunodeficiency syndrome-related lymphomagenesis. J Natl Cancer Inst Monogr. 1998;23:95–100.Google Scholar
  49. 49.
    Gallagher B, Wang Z, Schymura MJ, Kahn A, Fordyce EJ. Cancer incidence in New York State acquired immunodeficiency syndrome patients. Am J Epidemiol. 2001;154:544–56.PubMedCrossRefGoogle Scholar
  50. 50.
    Genet P, Chaoui D, Masse V, Al Jijakli A, Arakelyan N, Sutton L. Anaplastic large cell lymphoma occurring in an HIV-positive patient. Case Rep Hematol. 2012;2012:180204.PubMedCentralPubMedGoogle Scholar
  51. 51.
    Geriniere L, Bastion Y, Dumontet C, Salles G, Espinouse D, Coiffier B. Heterogeneity of acute lymphoblastic leukemia in HIV-seropositive patients. Ann Oncol. 1994;5:437–40.PubMedGoogle Scholar
  52. 52.
    Ghosh M, Banerjee M, Chakraborty S, Bhattacharyya S. Successful outcome in a HIV infected child presenting with Pre-B Acute Lymphoblastic Leukemia. Indian J Pediatr. 2012;79:267–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS. 2014;28:2313–8.PubMedCentralPubMedCrossRefGoogle Scholar
  54. 54.
    Glaser SL, Clarke CA, Gulley ML, Craig FE, Digiuseppe JA, Dorfman RF, Mann RB, Ambinder RF. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988–1998. Cancer. 2003;98:300–9.PubMedCrossRefGoogle Scholar
  55. 55.
    Grogg KL, Miller RF, Dogan A. HIV infection and lymphoma. J Clin Pathol. 2007;60:1365–72.PubMedCentralPubMedCrossRefGoogle Scholar
  56. 56.
    Grulich AE, Wan X, Law MG, Coates M, Kaldor JM. Risk of cancer in people with AIDS. AIDS. 1999;13:839–43.PubMedCrossRefGoogle Scholar
  57. 57.
    Gujral S, Shet TM, Kane SV. Morphological spectrum of AIDS-related plasmablastic lymphomas. Indian J Pathol Microbiol. 2008;51:121–4.PubMedCrossRefGoogle Scholar
  58. 58.
    Hagiwara S, Yotsumoto M, Odawara T, Ajisawa A, Uehira T, Nagai H, Tanuma J, Okada S. Non-AIDS-defining hematological malignancies in HIV-infected patients: an epidemiological study in Japan. AIDS. 2013;27:279–83.PubMedCrossRefGoogle Scholar
  59. 59.
    Hall JS, Usher S, Byers RJ, Higgins RC, Memon D, Radford JA, Linton KM. QuantiGene plex represents a promising diagnostic tool for cell-of-origin subtyping of diffuse large B-cell lymphoma. J Mol Diagn. 2015;17:402–11.PubMedCrossRefGoogle Scholar
  60. 60.
    Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farinha P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO, Chan WC. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–82.PubMedCrossRefGoogle Scholar
  61. 61.
    Hentrich M, Rockstroh J, Sandner R, Brack N, Hartenstein R. Acute myelogenous leukaemia and myelomonocytic blast crisis following polycythemia vera in HIV positive patients: report of cases and review of the literature. Ann Oncol. 2000;11:195–200.PubMedCrossRefGoogle Scholar
  62. 62.
    Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, Bernd HW, Cogliatti SB, Dierlamm J, Feller AC, Hansmann ML, Haralambieva E, Harder L, Hasenclever D, Kuhn M, Lenze D, Lichter P, Martin-Subero JI, Moller P, Muller-Hermelink HK, Ott G, Parwaresch RM, Pott C, Rosenwald A, Rosolowski M, Schwaenen C, Sturzenhofecker B, Szczepanowski M, Trautmann H, Wacker HH, Spang R, Loeffler M, Trumper L, Stein H, Siebert R. A biologic definition of Burkitt’s lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006;354:2419–30.PubMedCrossRefGoogle Scholar
  63. 63.
    Hussain SK, Zhu W, Chang SC, Breen EC, Vendrame E, Magpantay L, Widney D, Conn D, Sehl M, Jacobson LP, Bream JH, Wolinsky S, Rinaldo CR, Ambinder RF, Detels R, Zhang ZF, Martinez-Maza O. Serum levels of the chemokine CXCL13, genetic variation in CXCL13 and its receptor CXCR5, and HIV-associated non-hodgkin B-cell lymphoma risk. Cancer Epidemiol Biomarkers Prev. 2013;22:295–307.PubMedCentralPubMedCrossRefGoogle Scholar
  64. 64.
    Kaloutsi V, Kohlmeyer U, Maschek H, Nafe R, Choritz H, Amor A, Georgii A. Comparison of bone marrow and hematologic findings in patients with human immunodeficiency virus infection and those with myelodysplastic syndromes and infectious diseases. Am J Clin Pathol. 1994;101:123–9.PubMedGoogle Scholar
  65. 65.
    Kaplan MH, Susin M, Pahwa SG, Fetten J, Allen SL, Lichtman S, Sarngadharan MG, Gallo RC. Neoplastic complications of HTLV-III infection. Lymphomas and solid tumors. Am J Med. 1987;82:389–96.PubMedCrossRefGoogle Scholar
  66. 66.
    Karcher DS, Frost AR. The bone marrow in human immunodeficiency virus (HIV)-related disease. Morphology and clinical correlation. Am J Clin Pathol. 1991;95:63–71.PubMedGoogle Scholar
  67. 67.
    Katsarou O, Terpos E, Patsouris E, Peristeris P, Viniou N, Kapsimali V, Karafoulidou A. Myelodysplastic features in patients with long-term HIV infection and haemophilia. Haemophilia. 2001;7:47–52.PubMedCrossRefGoogle Scholar
  68. 68.
    Katzel JA, Kempin SJ, Lagmay-Fuentes P, Cook WA, Siegal FP, Henriquez LE, Lee MH, Vesole DH. Therapy-related leukemia in patients with human immunodeficiency virus infection after treatment for non-Hodgkin lymphoma. Am J Hematol. 2008;83:937–8.PubMedCrossRefGoogle Scholar
  69. 69.
    Kluin PM, Harris NL, Stein H, Leoncini L, Raphael M, Campo E, Jaffe ES. B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.Google Scholar
  70. 70.
    Knowles DM. Neoplastic hematopathology. Baltimore: Williams and Wilkins; 2001.Google Scholar
  71. 71.
    Knowles DM, Chamulak GA, Subar M, Burke JS, Dugan M, Wernz J, Slywitzky C, Pelicci P-G, Dalla-Favera R, Raphael B. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med. 1988;108:744–53.PubMedCrossRefGoogle Scholar
  72. 72.
    Koduri PR, Sherer R, Teter C. Polycythemia in patients infected with human immunodeficiency virus-1. Am J Hematol. 2000;64:80–1.PubMedCrossRefGoogle Scholar
  73. 73.
    Kundu RK, Sangiorgi F, Wu LY, Pattengale PK, Hinton DR, Gill PS, Maxson R. Expression of the human immunodeficiency virus-Tat gene in lymphoid tissues of transgenic mice is associated with B-cell lymphoma. Blood. 1999;94:275–82.PubMedGoogle Scholar
  74. 74.
    Levine AM, Sadeghi S, Espina B, Tulpule A, Nathwani B. Characteristics of indolent non-Hodgkin lymphoma in patients with type 1 human immunodeficiency virus infection. Cancer. 2002;94:1500–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Liapis K, Clear A, Owen A, Coutinho R, Greaves P, Lee AM, Montoto S, Calaminici M, Gribben JG. The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies. Blood. 2013;122:424–33.PubMedCentralPubMedCrossRefGoogle Scholar
  76. 76.
    Lorand-Metze I, Morais SL, Souza CA. Chronic myeloid leukemia in a homosexual HIV-seropositive man. AIDS. 1990;4:923–4.PubMedCrossRefGoogle Scholar
  77. 77.
    Lorenzon D, Perin T, Bulian P, De Re V, Caggiari L, Michieli M, Manuele R, Spina M, Gattei V, Fasan M, Tirelli U, Canzonieri V. Human immunodeficiency virus-associated precursor T-lymphoblastic leukemia/lymphoblastic lymphoma: report of a case and review of the literature. Hum Pathol. 2009;40:1045–9.PubMedCrossRefGoogle Scholar
  78. 78.
    Louw VJ. Chronic myeloid leukaemia in South Africa. Hematology. 2012;17 Suppl 1:S75–8.PubMedGoogle Scholar
  79. 79.
    Lum GH, Cosgriff TM, Byrne R, Reddy V. Primary T-cell lymphoma of muscle in a patient infected with human immunodeficiency virus. Am J Med. 1993;95:545–6.PubMedCrossRefGoogle Scholar
  80. 80.
    Luzzi A, Morettini F, Gazaneo S, Mundo L, Onnis A, Mannucci S, Rogena EA, Bellan C, Leoncini L, de Falco G. HIV-1 Tat induces DNMT over-expression through microRNA dysregulation in HIV-related non Hodgkin lymphomas. Infect Agent Cancer. 2014;9:41.PubMedCentralPubMedCrossRefGoogle Scholar
  81. 81.
    Manfredi R, Sabbatani S, Chiodo F. Advanced acute myelogenous leukaemia (AML) during HAART-treated HIV disease, manifesting initially as a thyroid mass. Scand J Infect Dis. 2005;37:781–3.PubMedCrossRefGoogle Scholar
  82. 82.
    Mani D, Dorer RK, Aboulafia DM. Therapy-related acute myeloid leukemia following HIV-associated lymphoma. Clin Lymphoma Myeloma. 2009;9:316–9.PubMedCrossRefGoogle Scholar
  83. 83.
    Martin SI, Zukerberg L, Robbins GK. Reactive Epstein-Barr virus-related polyclonal lymphoproliferative disorder in a patient with AIDS. Clin Infect Dis. 2005;41:e76–9.PubMedCrossRefGoogle Scholar
  84. 84.
    Masque-Soler N, Szczepanowski M, Kohler CW, Spang R, Klapper W. Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens. Blood. 2013;122:1985–6.PubMedCrossRefGoogle Scholar
  85. 85.
    Matsumoto Y, Nomura K, Ueda K, Satoh K, Yasuda N, Taki T, Yokota S, Horiike S, Okanoue T, Taniwaki M. Human herpesvirus 8-negative malignant effusion lymphoma: a distinct clinical entity and successful treatment with rituximab. Leuk Lymphoma. 2005;46:415–9.PubMedCrossRefGoogle Scholar
  86. 86.
    Mbanya DN, Minkoulou EM, Kaptue LN. HIV-1 infection in adults with haematological malignancies in Yaounde, Cameroon. West Afr J Med. 2002;21:183–4.PubMedGoogle Scholar
  87. 87.
    Mckenna RW, Kyle RA, Kuehl WM, Grogan TM, Harris NL, Coupland RW. Plasma cell neoplasms. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.Google Scholar
  88. 88.
    Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Said J, Knowles DM. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpesvirus. Blood. 1996;88:645–56.PubMedGoogle Scholar
  89. 89.
    Nador RG, Chadburn A, Gundappa G, Cesarman E, Said JW, Knowles DM. Human immunodeficiency virus (HIV)-associated polymorphic lymphoproliferative disorders. Am J Surg Pathol. 2003;27:293–302.PubMedCrossRefGoogle Scholar
  90. 90.
    Newton R, Ziegler J, Beral V, Mbidde E, Carpenter L, Wabinga H, Mbulaiteye S, Appleby P, Reeves G, Jaffe H, Uganda Kaposi’s Sarcoma Study, G. A case-control study of human immunodeficiency virus infection and cancer in adults and children residing in Kampala, Uganda. Int J Cancer. 2001;92:622–7.PubMedCrossRefGoogle Scholar
  91. 91.
    Nogues X, Supervia A, Knobel H, Lopez-Colomes JL, Serrano S, Abella E. Multiple myeloma and AIDS. Am J Hematol. 1996;53:210–1.PubMedCrossRefGoogle Scholar
  92. 92.
    Pande A, Bhattacharyya M, Pain S, Samanta A. Study of bone marrow changes in antiretroviral naive human immunodeficiency virus-infected anemic patients. Indian J Pathol Microbiol. 2011;54:542–6.PubMedCrossRefGoogle Scholar
  93. 93.
    Paner GP, Jensen J, Foreman KE, Reyes CV. HIV and HHV-8 negative primary effusion lymphoma in a patient with hepatitis C virus-related liver cirrhosis. Leuk Lymphoma. 2003;44:1811–4.PubMedCrossRefGoogle Scholar
  94. 94.
    Park LS, Tate JP, Rodriguez-Barradas MC, Rimland D, Goetz MB, Gibert C, Brown ST, Kelley MJ, Justice AC, Dubrow R. Cancer incidence in HIV-infected versus uninfected veterans: comparison of cancer registry and ICD-9 code diagnoses. J AIDS Clin Res. 2014;5:1000318.PubMedCentralPubMedGoogle Scholar
  95. 95.
    Patel M, Philip V, Fazel F, Lakha A, Vorog A, Ali N, Karstaedt A, Pather S. Human immunodeficiency virus infection and chronic myeloid leukemia. Leuk Res. 2012;36:1334–8.PubMedCrossRefGoogle Scholar
  96. 96.
    Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, Holmberg SD, Brooks JT. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med. 2008;148:728–36.PubMedCrossRefGoogle Scholar
  97. 97.
    Patra SK, Soren M, Das AK, Mangal S. A rare case of multiple myeloma (Mm) presented with pancytopaenia in a patient of HIV – at very early age. J Clin Diagn Res. 2015;9:ED07–8.PubMedCentralPubMedGoogle Scholar
  98. 98.
    Perez K, Castillo J, Dezube BJ, Pantanowitz L. Human immunodeficiency virus-associated anaplastic large cell lymphoma. Leuk Lymphoma. 2010;51:430–8.PubMedCrossRefGoogle Scholar
  99. 99.
    Polizzotto MN, Skinner M, Cole-Sinclair MF, Opat SS, Spencer A, Avery S. Allo-SCT for hematological malignancies in the setting of HIV. Bone Marrow Transplant. 2010;45:584–6.PubMedCrossRefGoogle Scholar
  100. 100.
    Presant CA, Gala K, Wiseman C, Kennedy P, Blayney D, Sheibani K, Winberg CD, Rasheed S. Human immunodeficiency virus-associated T-cell lymphoblastic lymphoma in AIDS. Cancer. 1987;60:1459–61.PubMedCrossRefGoogle Scholar
  101. 101.
    Rabbitts TH, Hamlyn PH, Baer R. Altered nucleotide sequences of a translocated c-myc gene in Burkitt lymphoma. Nature. 1983;306:760–5.PubMedCrossRefGoogle Scholar
  102. 102.
    Raffetti E, Albini L, Gotti D, Segala D, Maggiolo F, Di Filippo E, Saracino A, Ladisa N, Lapadula G, Fornabaio C, Castelnuovo F, Casari S, Fabbiani M, Pierotti P, Donato F, Quiros-Roldan E, Cohort M. Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study. BMC Public Health. 2015;15:235.PubMedCentralPubMedCrossRefGoogle Scholar
  103. 103.
    Raphaël M, Said J, Borisch B, Cesarman E, Harris NL. Lymphomas associated with HIV infection. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.Google Scholar
  104. 104.
    Ravandi F, Verma A, Ridgeway J, Pursell K. Chronic lymphocytic leukemia (B-CLL) occurring with human immunodeficiency virus (HIV) infection: implications. Leuk Res. 2003;27:853–7.PubMedCrossRefGoogle Scholar
  105. 105.
    Rea D, Delecluse HJ, Hamilton-Dutoit SJ, Marelle L, Joab I, Edelman L, Finet JF, Raphael M. Epstein-Barr virus latent and replicative gene expression in post-transplant lymphoproliferative disorders and AIDS-related non-Hodgkin’s lymphomas. French Study Group of Pathology for HIV-associated Tumors. Ann Oncol. 1994;5 Suppl 1:113–6.PubMedCrossRefGoogle Scholar
  106. 106.
    Rieg S, Lubbert M, Kern WV, Timme S, Gartner F, Rump JA. Myelodysplastic syndrome with complex karyotype associated with long-term highly active antiretroviral therapy. Br J Haematol. 2009;145:670–3.PubMedCrossRefGoogle Scholar
  107. 107.
    Rizzo M, Magro G, Castaldo P, Tucci L. Granulocytic sarcoma (chloroma) in HIV patient: a report. Forensic Sci Int. 2004;146(Suppl):S57–8.PubMedCrossRefGoogle Scholar
  108. 108.
    Rozza-De-Menezes RE, Jeronimo Ferreira S, Lenzi Capella D, Schwartz S, Willrich AH. Gingival anaplastic large-cell lymphoma mimicking hyperplastic benignancy as the first clinical manifestation of AIDS: a case report and review of the literature. Case Rep Dent. 2013;2013:852932.PubMedCentralPubMedGoogle Scholar
  109. 109.
    Saggini A, Anemona L, Chimenti S, Sarmati L, Torti C, Di Stefani A, Bianchi L. HIV-associated primary cutaneous anaplastic large cell lymphoma: a clinicopathological subset with more aggressive behavior? Case report and review of the literature. J Cutan Pathol. 2012;39:1100–9.PubMedCrossRefGoogle Scholar
  110. 110.
    Said J, Cesarman E, Knowles D. Lymphadenopathy and the lymphoid neoplasms associated with HIV infection and other causes of immunosuppression. In: Orazzi AWL, Foucar K, Knowles DM, editors. Knowles’ neoplastic hematopathology. 3rd ed. Baltimore: Wolters Kuwer/Williams and Wilkins; 2014.Google Scholar
  111. 111.
    Saini N, Hochberg EP, Linden EA, Jha S, Grohs HK, Sohani AR. HHV8-negative primary effusion lymphoma of B-cell Lineage: two cases and a comprehensive review of the literature. Case Rep Oncol Med. 2013;2013:292301.PubMedCentralPubMedGoogle Scholar
  112. 112.
    Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, Raffeld M. p53 mutation is associated with progression in follicular lymphomas. Blood. 1993;82:1994–2004.PubMedGoogle Scholar
  113. 113.
    Sassaki MG, Souza CA, Siciliano RF, Leite AG, Padilha SL. Polycythemia vera in a patient with the human immunodeficiency virus: a case report. Braz J Infect Dis. 2000;4:204–7.PubMedGoogle Scholar
  114. 114.
    Schlaberg R, Fisher JG, Flamm MJ, Murty VV, Bhagat G, Alobeid B. Chronic myeloid leukemia and HIV-infection. Leuk Lymphoma. 2008;49:1155–60.PubMedCrossRefGoogle Scholar
  115. 115.
    Selik RM, Rabkin CS. Cancer death rates associated with human immunodeficiency virus infection in the United States. J Natl Cancer Inst. 1998;90:1300–2.PubMedCrossRefGoogle Scholar
  116. 116.
    Shiels MS, Engels EA. Increased risk of histologically defined cancer subtypes in human immunodeficiency virus-infected individuals: clues for possible immunosuppression-related or infectious etiology. Cancer. 2012;118:4869–76.PubMedCentralPubMedCrossRefGoogle Scholar
  117. 117.
    Shiels MS, Pfeiffer RM, Gail MH, Hall HI, Li J, Chaturvedi AK, Bhatia K, Uldrick TS, Yarchoan R, Goedert JJ, Engels EA. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011;103:753–62.PubMedCentralPubMedCrossRefGoogle Scholar
  118. 118.
    Simard EP, Pfeiffer RM, Engels EA. Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med. 2010;170:1337–45.PubMedCentralPubMedCrossRefGoogle Scholar
  119. 119.
    Stefan DC, Dippenaar A, de Bruin G, Uys R, van Toorn R. Challenges to treatment of leukemia in HIV-positive children. J Trop Pediatr. 2012;58:521–2.PubMedCrossRefGoogle Scholar
  120. 120.
    Stein H, Harris NL, Campo E. Plasmablastic lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2008.Google Scholar
  121. 121.
    Sutton L, Guenel P, Tanguy ML, Rio B, Dhedin N, Casassus P, Lortholary O, French Study Group on Acute Myeloid Leukaemia in, H. I. V. I. P. Acute myeloid leukaemia in human immunodeficiency virus-infected adults: epidemiology, treatment feasibility and outcome. Br J Haematol. 2001;112:900–8.PubMedCrossRefGoogle Scholar
  122. 122.
    Takahashi K, Yabe M, Shapira I, Pierce S, Garcia-Manero G, Varma M. Clinical and cytogenetic characteristics of myelodysplastic syndrome in patients with HIV infection. Leuk Res. 2012;36:1376–9.PubMedCrossRefGoogle Scholar
  123. 123.
    Tao J, Valderrama E. Epstein-Barr virus-associated polymorphic B-cell lymphoproliferative disorders in the lungs of children with AIDS: a report of two cases. Am J Surg Pathol. 1999;23:560–6.PubMedCrossRefGoogle Scholar
  124. 124.
    Thiele J, Titius BR, Quitmann H, Fischer R, Salzberger B, Dienemann D, Stein H. Megakaryocytopoiesis in bone marrow biopsies of patients with acquired immunodeficiency syndrome (AIDS). An immunohistochemical and morphometric evaluation with special emphasis on myelodysplastic features and precursor cells. Pathol Res Pract. 1992;188:722–8.PubMedCrossRefGoogle Scholar
  125. 125.
    Thiele J, Zirbes TK, Bertsch HP, Titius BR, Lorenzen J, Fischer R. AIDS-related bone marrow lesions – myelodysplastic features or predominant inflammatory-reactive changes (HIV-myelopathy)? A comparative morphometric study by immunohistochemistry with special emphasis on apoptosis and PCNA-labeling. Anal Cell Pathol. 1996;11:141–57.PubMedGoogle Scholar
  126. 126.
    Tomonari A, Takahashi S, Shimohakamada Y, Ooi J, Takasugi K, Ohno N, Konuma T, Uchimaru K, Tojo A, Odawara T, Nakamura T, Iwamoto A, Asano S. Unrelated cord blood transplantation for a human immunodeficiency virus-1-seropositive patient with acute lymphoblastic leukemia. Bone Marrow Transplant. 2005;36:261–2.PubMedCrossRefGoogle Scholar
  127. 127.
    Tsagarakis NJ, Argyrou A, Gortzolidis G, Kentrou N, Papadhimitriou SI, Tzanetou K, Kakiopoulos G, Papadimitriou KA, Skoumi D, Paterakis G. Report of an HIV and HHV-8 negative case of primary effusion lymphoma with idiopathic T4 lymphocytopenia. Int J Hematol. 2009;90:94–8.PubMedCrossRefGoogle Scholar
  128. 128.
    Tullu MS, Date NB, Ghildiyal RG, Modi CJ. Acute myelogenous leukemia in a child with HIV infection. Eur J Pediatr. 2010;169:629–31.PubMedCrossRefGoogle Scholar
  129. 129.
    Valera A, Balague O, Colomo L, Martinez A, Delabie J, Taddesse-Heath L, Jaffe ES, Campo E. IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas. Am J Surg Pathol. 2010;34:1686–94.PubMedCentralPubMedGoogle Scholar
  130. 130.
    Verneris MR, Tuel L, Seibel NL. Pediatric HIV infection and chronic myelogenous leukemia. Pediatr AIDS HIV Infect. 1995;6:292–4.PubMedGoogle Scholar
  131. 131.
    Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, Tzankov A, Wen W, Liu WM, Kahl BS, D’amore ES, Montes-Moreno S, Dybkaer K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HY, O’neill S, Dunphy CH, Hsi ED, Zhao XF, Go RS, Choi WW, Zhou F, Czader M, Tong J, Zhao X, van Krieken JH, Huang Q, Ai W, Etzell J, Ponzoni M, Ferreri AJ, Piris MA, Moller MB, Bueso-Ramos CE, Medeiros LJ, Wu L, Young KH. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia. 2012;26:2103–13.PubMedCentralPubMedCrossRefGoogle Scholar
  132. 132.
    Vorkas CK, Vaamonde CM, Glesby MJ. Testosterone replacement therapy and polycythemia in HIV-infected patients. AIDS. 2012;26:243–5.PubMedCentralPubMedCrossRefGoogle Scholar
  133. 133.
    Wang X, Nathan S, Catchatourian R, Richter 3rd H, Kovarik P. Polymorphic lymphoid proliferation presenting as ileocecal intussusception. Ann Hematol. 2007;86:453–4.PubMedCrossRefGoogle Scholar
  134. 134.
    Willocks L, Ludlam CA, Welsby PD. Polycythaemia and HIV infection. Lancet. 1990;336:812–3.PubMedCrossRefGoogle Scholar
  135. 135.
    Xu Q, Tan C, Ni S, Wang Q, Wu F, Liu F, Ye X, Meng X, Sheng W, Du X. Identification and validation of a two-gene expression index for subtype classification and prognosis in diffuse large B-cell lymphoma. Sci Rep. 2015;5:10006.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Pathology and Laboratory MedicineWeill Cornell Medical CollegeNew YorkUSA

Personalised recommendations